New chemo delivery method targets brain cancer spread in breast cancer patients

NCT ID NCT06230055

First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 18 times

Summary

This study tests if giving chemotherapy directly into the fluid around the brain (via a small device called an Ommaya reservoir) along with standard body chemotherapy works better than standard chemotherapy alone for people with HER2-negative breast cancer that has spread to the brain lining. The trial involves 37 adults and aims to see if the combination slows down brain-related cancer progression and improves quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HER2-NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.